BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26898741)

  • 1. Polymer Drug Conjugates: Recent Advancements in Various Diseases.
    Singh J; Desai S; Yadav S; Narasimhan B; Kaur H
    Curr Pharm Des; 2016; 22(19):2821-43. PubMed ID: 26898741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPMA-based polymeric conjugates in anticancer therapeutics.
    Rani S; Gupta U
    Drug Discov Today; 2020 Jun; 25(6):997-1012. PubMed ID: 32334073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the role of polymeric conjugates toward anti-cancer drug delivery: Current trends and future projections.
    Khan J; Alexander A; Ajazuddin ; Saraf S; Saraf S
    Int J Pharm; 2018 Sep; 548(1):500-514. PubMed ID: 29964172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer-drug conjugates: present state of play and future perspectives.
    Pang X; Du HL; Zhang HQ; Zhai YJ; Zhai GX
    Drug Discov Today; 2013 Dec; 18(23-24):1316-22. PubMed ID: 24055841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymer--drug conjugates as nano-sized medicines.
    Canal F; Sanchis J; Vicent MJ
    Curr Opin Biotechnol; 2011 Dec; 22(6):894-900. PubMed ID: 21724381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable amphiphilic polymer-drug conjugate micelles.
    Hu X; Jing X
    Expert Opin Drug Deliv; 2009 Oct; 6(10):1079-90. PubMed ID: 19645633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymer-drug conjugate therapeutics: advances, insights and prospects.
    Ekladious I; Colson YL; Grinstaff MW
    Nat Rev Drug Discov; 2019 Apr; 18(4):273-294. PubMed ID: 30542076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities.
    Duncan R; Vicent MJ
    Adv Drug Deliv Rev; 2010 Feb; 62(2):272-82. PubMed ID: 20005271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer.
    Duncan R; Vicent MJ; Greco F; Nicholson RI
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S189-99. PubMed ID: 16113096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioconjugation in pharmaceutical chemistry.
    Veronese FM; Morpurgo M
    Farmaco; 1999 Aug; 54(8):497-516. PubMed ID: 10510847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAFT-derived polymer-drug conjugates: poly(hydroxypropyl methacrylamide) (HPMA)-7-ethyl-10-hydroxycamptothecin (SN-38) conjugates.
    Williams CC; Thang SH; Hantke T; Vogel U; Seeberger PH; Tsanaktsidis J; Lepenies B
    ChemMedChem; 2012 Feb; 7(2):281-91. PubMed ID: 22144261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micelle-like nanoassemblies based on polymer-drug conjugates as an emerging platform for drug delivery.
    Liu Z; Wang Y; Zhang N
    Expert Opin Drug Deliv; 2012 Jul; 9(7):805-22. PubMed ID: 22607499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond oncology--application of HPMA copolymers in non-cancerous diseases.
    Liu XM; Miller SC; Wang D
    Adv Drug Deliv Rev; 2010 Feb; 62(2):258-71. PubMed ID: 19909776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted polymer-drug conjugates: Current progress and future perspective.
    Xu H; Ma H; Yang P; Zhang X; Wu X; Yin W; Wang H; Xu D
    Colloids Surf B Biointerfaces; 2015 Dec; 136():729-34. PubMed ID: 26513756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin-targeted nano-sized polymeric systems for paclitaxel conjugation: a comparative study.
    Eldar-Boock A; Blau R; Ryppa C; Baabur-Cohen H; Many A; Vicent MJ; Kratz F; Sanchis J; Satchi-Fainaro R
    J Drug Target; 2017; 25(9-10):829-844. PubMed ID: 28737432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Light at the End of the Tunnel-Second Generation HPMA Conjugates for Cancer Treatment.
    Yang J; Kopeček J
    Curr Opin Colloid Interface Sci; 2017 Sep; 31():30-42. PubMed ID: 29276426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer-drug conjugates for novel molecular targets.
    Sanchis J; Canal F; Lucas R; Vicent MJ
    Nanomedicine (Lond); 2010 Aug; 5(6):915-35. PubMed ID: 20735226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of polymer-drug conjugates in organ-specific delivery systems.
    Paramjot ; Khan NM; Kapahi H; Kumar S; Bhardwaj TR; Arora S; Mishra N
    J Drug Target; 2015 Jun; 23(5):387-416. PubMed ID: 25720345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.